INSIGHTS ON DRUG DEVELOPMENT
-
Discovery Core Rheometer: Easy To Use. Hard To Beat.
Explore how advanced rheological testing delivers deeper insight into material behavior, from flow and yield stress to quality control decisions, using guided workflows that simplify setup.
-
Considerations In Design And Development Of Novel Combination Drug-Delivery Devices
Poor scoping kills drug delivery device programs before they start. Learn how to define the right problem, assess risk early, and set boundaries that protect your timeline and budget.
-
The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins
Protein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.
-
Developing A Quantitative Surrogate Peptide Assay
Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.
-
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions11/20/2025
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
-
How Patent Expirations Will Reshape The Dry Powder Inhaler (DPI) Market4/10/2026
Patent expirations on dry powder inhalers are driving rapid market competition. Discover how optimized mechanical dosing speeds scale-up and protects profit margins.
-
Rheology Is An Accurate Predictor Of Pharmaceutical Lotion Stability5/6/2026
Rheological creep testing provides a rapid way to predict pharmaceutical lotion stability by linking steady-state viscosity to particle settling behavior, enabling reliable shelf-life estimates.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
Using Residual DNA Quantification Data To De-Risk mAb Development6/11/2026
Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.
DRUG DEVELOPMENT SOLUTIONS
-
Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.
-
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.
-
For workflows where trace contamination can derail sensitivity, consistency matters. See how rigorously tested reagents and isolation chemistries support cleaner controls and more confident results.
-
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.